Aspargo Labs, Inc
Clinical trials sponsored by Aspargo Labs, Inc, explained in plain language.
-
Does alcohol slow down your ED meds? new study investigates
Symptom relief Not yet recruitingThis study looks at whether having a moderate amount of alcohol changes how quickly and how well a liquid form of sildenafil (the active ingredient in Viagra) works for erectile dysfunction. Thirty-six men will take the medication under different conditions—with and without alcoh…
Phase: PHASE2 • Sponsor: Aspargo Labs, Inc • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
New ED drugs hezkue and hezkue turbo face off against Viagra-Like pills
Symptom relief Not yet recruitingThis study tests two new erectile dysfunction (ED) treatments, Hezkue and Hezkue Turbo, against several standard sildenafil products. About 200 men with ED will use one of the assigned treatments as needed for 12 weeks. Researchers will measure improvements in erectile function, …
Phase: PHASE2 • Sponsor: Aspargo Labs, Inc • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC
-
New sildenafil versions tested for better absorption
Symptom relief Not yet recruitingThis early-stage study will compare how well different versions of sildenafil (the drug in Viagra) are absorbed and tolerated in 72 healthy adult men after a meal. The goal is to see if newer formulations, Hezkue and Hezkue Turbo, work differently than other commercial products. …
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC
-
New sildenafil drink mix studied after alcohol – what happens?
Knowledge-focused Not yet recruitingThis early-stage study will give 24 healthy adults a single dose of Hezkue oral sildenafil suspension after they drink a moderate amount of alcohol. Researchers will measure how the drug enters the blood and how quickly it works. The goal is to understand any changes caused by al…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 23, 2026 23:32 UTC
-
Liquid metformin vs. pills: which works better?
Knowledge-focused Not yet recruitingThis study tests if a liquid form of metformin (a common diabetes drug) works as well as the standard tablet. Healthy adults aged 18-55 will take both versions at different times, and researchers will measure drug levels in their blood. The goal is to see if the liquid is a good …
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:04 UTC
-
Liquid metformin: a gentler option for diabetes patients?
Knowledge-focused Not yet recruitingThis study aims to see if liquid metformin causes fewer stomach problems than the standard tablet form. Twenty-four healthy adults will try both liquid versions and tablets, and researchers will track any side effects. The goal is to find a more tolerable option for people who ne…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Liquid metformin put to the test against pills in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study will test how two different liquid forms of metformin affect blood sugar compared to regular metformin tablets. Twenty-four healthy adults will take short-term doses and have their blood glucose measured. The goal is to see if the liquid versions work diffe…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:05 UTC
-
Liquid metformin: easier swallowing or just different?
Knowledge-focused Not yet recruitingThis study looks at how a new liquid version of metformin (a common diabetes medicine) is absorbed by the body compared to regular tablets. Twenty-four healthy adults will take both forms in a random order, with blood tests to measure drug levels. The goal is to see if the liquid…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Liquid metformin study: will it work better than pills?
Knowledge-focused Not yet recruitingThis study looks at how two liquid forms of metformin are absorbed by the body compared to standard tablets. It involves 24 healthy adults aged 18 to 55. The goal is to gather information, not to treat any disease.
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC